In the early 1950s, respiratory therapy was a physically demanding discipline. Therapists spent hours each day performing manual chest percussion on patients with chronic lung conditions — rhythmically clapping on patients' chests and backs to help loosen and mobilize trapped secretions. The technique was effective, but it took a toll. Therapists developed repetitive strain injuries, and the quality of treatment varied depending on the therapist's stamina and technique on any given day.
G5 General Physiotherapy was founded in 1953 with a straightforward mission: build a mechanical device that could replicate the therapist's hand motion with greater consistency, reduced physical strain, and the ability to sustain treatment over longer sessions. The company's founders — working from a small facility in the St. Louis, Missouri area — developed the first G5 mechanical percussor, a device that would lay the foundation for more than six decades of innovation in percussion therapy.
What set the early G5 devices apart from other mechanical vibrators of the era was the gyratory motion. Rather than simply vibrating in a single plane (like a standard massager) or hammering in a linear piston motion, the G5 mechanism produced a circular, orbital movement combined with vertical percussion. This gyratory action was designed to more closely replicate the natural motion of a therapist's cupped hand during chest percussion — a broader, more distributed force pattern that was intended to be both effective and comfortable for patients.
This patented gyratory technology became the defining characteristic of G5 products and remains central to the company's devices today. While competitors have introduced various vibration and percussion mechanisms over the decades, the gyratory motion continues to distinguish G5 in the market.
Through the 1960s and 1970s, G5 percussion devices gained steady adoption in hospitals, rehabilitation centers, and respiratory therapy departments across the United States. As the field of respiratory therapy professionalized — with the establishment of credentialing programs and clinical practice guidelines — mechanical percussion became an accepted component of chest physiotherapy protocols.
During this period, G5 expanded its product line to include devices designed for different clinical settings and patient populations. The company developed specialized applicators for various body regions and treatment applications, transforming what had been a single-purpose respiratory device into a versatile therapeutic tool used across multiple clinical disciplines.
By the 1980s, G5 devices were a common sight in hospital respiratory therapy departments, physical therapy clinics, and chiropractic offices. The company had established relationships with major medical distributors and its products were being used in clinical settings around the world.
One of the most significant chapters in G5's history was the development of the Neocussor — a specialized percussion device designed specifically for neonatal and pediatric patients. Premature infants and newborns with respiratory conditions present unique challenges: their bodies are fragile, their airways are tiny, and the margin for error is extremely small.
The Neocussor was engineered from the ground up for this vulnerable population. It features a lightweight design, ultra-gentle percussion settings, and specialized small applicators sized for neonatal patients. The device was designed to deliver the therapeutic benefits of percussion therapy at force levels appropriate for the smallest and most delicate patients.
Today, the Neocussor is used in neonatal intensive care units (NICUs) across the country, where it is part of the respiratory care protocol for premature infants and newborns with conditions such as respiratory distress syndrome, meconium aspiration, and bronchopulmonary dysplasia. Learn more about neonatal respiratory care.
Throughout its history, G5 has maintained a commitment to regulatory compliance and quality standards. The company's flagship products — including the Vibracare and Neocussor — are FDA 510(k) cleared as Class II medical devices. This clearance requires demonstrating that the devices are substantially equivalent to legally marketed predicate devices and that they meet applicable safety and performance standards.
This regulatory status is more than a compliance checkbox. It reflects G5's position as a manufacturer of medical devices — not consumer wellness gadgets — and it has practical implications for patients and healthcare providers. FDA clearance supports insurance reimbursement, HSA/FSA eligibility, and clinical adoption in regulated healthcare settings. Learn about HSA/FSA eligibility for G5 devices.
The most recent chapter in G5's evolution has been shaped by a broader trend in healthcare: the shift toward home-based therapy. As healthcare systems increasingly emphasize outpatient care, patient independence, and home health solutions, G5 has adapted its product line to serve patients outside of traditional clinical settings.
The G5 Vibracare represents the culmination of this evolution. Built on the same gyratory percussion technology that has defined G5 for decades, the Vibracare is designed for both clinical and home use. It features variable speed control, a comprehensive set of interchangeable applicators, and a form factor that is accessible to patients and caregivers — not just trained therapists.
The Vibracare serves a dual purpose: respiratory therapy (chest percussion for airway clearance) and musculoskeletal therapy (percussion massage for pain management and muscle recovery). This versatility makes it a practical investment for patients who may benefit from both applications.
More than seven decades after its founding, G5 General Physiotherapy remains headquartered in the St. Louis metropolitan area, where it continues to design, manufacture, and support its products. The company's focus has not wavered from its original mission: building reliable, effective percussion therapy devices that help patients breathe easier and live more comfortably.
As respiratory conditions like COPD continue to affect millions of Americans, and as the healthcare system continues its shift toward patient-centered, home-based care, the need for accessible, high-quality therapy devices is greater than ever. G5 is committed to meeting that need — with the same engineering rigor, clinical focus, and patient-first philosophy that has guided the company since 1953.
Explore our current product line in the G5 shop, or learn more about our company and the people behind the products.
To learn more about G5's current product lineup or discuss how percussion therapy can benefit your patients, contact our team or visit our For Professionals page for clinical resources and institutional ordering.
Join thousands of patients and caregivers who receive our expert guides, therapy tips, and exclusive offers.
No spam, ever. Unsubscribe anytime. We respect your privacy.
FDA-cleared percussion therapy devices designed to support respiratory health and pain management. Trusted by hospitals and families for over 60 years.
Not all percussion devices are created equal. For over 60 years, G5 General Physiotherapy has been the trusted originator of Directional-Percussion technology — a patented approach that fundamentally outperforms traditional straight-percussion methods.
If you're shopping for a percussion therapy device, you've likely encountered a confusing marketplace. Some devices are FDA-cleared medical instruments. Others are consumer massage tools marketed with vague health claims. This article explains what FDA clearance really means and why it matters.
Percussion therapy has been used in clinical settings for decades to support respiratory health and pain management. Learn how this time-tested technique works and why professional-grade devices differ from consumer alternatives.
